Composition containing S-adenosyl-L-methionine with excellent storage stability

US9700629B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9700629-B2
Application numberUS-201214238029-A
CountryUS
Kind codeB2
Filing dateJul 20, 2012
Priority dateAug 12, 2011
Publication dateJul 11, 2017
Grant dateJul 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a composition including S-adenosyl-L-methionine; and at least one kind of additive selected from carboxymethylcellulose, hydroxypropylcellulose, soybean polysaccharide, casein sodium, and zein, in which S-adenosyl-L-methionine is extracted from S-adenosyl-L-methionine-containing cells obtained by culturing a microorganism having an ability to produce SAMe, and the content of the additive in the composition falls within the range of 0.05 to 15 times by mass of S-adenosyl-L-methionine in the composition. The present invention provides a composition containing a high concentration of S-adenosyl-L-methionine, which is useful as a water-soluble physiologically active substance, and being excellent in storage stability and bioabsorbability. The present invention also relates to a molded article formed by using the composition and a method of producing the composition.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising, in admixture: a microorganism cell extract comprising S-adenosyl-L-methionine; and at least one additive selected from the group consisting of soybean polysaccharide, casein sodium, and zein, wherein: the microorganism cell extract comprising S-adenosyl-L-methionine is extracted from an S-adenosyl-L-methionine-containing cell obtained by culturing a microorganism having an ability to produce S-adenosl-L-methionine; a content of the S-adenosyl-L-methionine in the composition is in a range of 3% to 18.8% by mass, based on the dry mass of the composition; a content of the additive in the composition is in a range of 0.05 to 15 times by mass of the S-adenosyl-L-methionine in the composition; and the admixture of the microorganism cell extract comprising S-adenosyl-L-methionine and the at least one additive is produced by mixing the microorganism cell extract comprising S-adenosyl-L-methionine and the at least one additive. 2. The composition according to claim 1 , wherein the composition is solid. 3. A molded article comprising the composition according to claim 2 . 4. The composition according to claim 1 , comprising soybean polysaccharide. 5. The composition according to claim 1 , comprising casein sodium. 6. The composition according to claim 1 , comprising zein. 7. The composition according to claim 1 , wherein the microorganism belongs to the genus Saccharomyces, Candida, Pi chia, Mucor, Rhizopus, Brevibacterium, Corynebacterium, Esherichia , or Streptomyces. 8. The composition according to claim 1 , wherein the microorganism is Saccharomyces cerevisiae .

Assignees

Inventors

Classifications

  • Antihyperlipidemics · CPC title

  • for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title

  • for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia · CPC title

  • Antidepressants · CPC title

  • Hypnotics; Sedatives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9700629B2 cover?
The present invention relates to a composition including S-adenosyl-L-methionine; and at least one kind of additive selected from carboxymethylcellulose, hydroxypropylcellulose, soybean polysaccharide, casein sodium, and zein, in which S-adenosyl-L-methionine is extracted from S-adenosyl-L-methionine-containing cells obtained by culturing a microorganism having an ability to produce SAMe, and t…
Who is the assignee on this patent?
Takano Kentaro, Gayama Shinyo, Mitsubishi Gas Chemical Co
What technology area does this patent fall under?
Primary CPC classification A61K47/36. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).